Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Nutrients ; 14(12)2022 Jun 16.
Article in English | MEDLINE | ID: mdl-35745223

ABSTRACT

The role of moderate alcohol consumption in the evolution of NAFLD is still debated. The aim of this study is to evaluate the impact of current and lifelong alcohol consumption in patients with NAFLD. From 2015 to 2020, we enrolled 276 consecutive patients fulfilling criteria of NAFLD (alcohol consumption up to 140 g/week for women and 210 g/week for men). According to their current alcohol intake per week, patients were divided in: abstainers, very low consumers (C1: <70 g/week) and moderate consumers (C2). We created a new tool, called LACU (Lifetime Alcohol Consuming Unit) to estimate the alcohol exposure across lifetime: 1 LACU was defined as 7 alcohol units per week for 1 drinking year. Patients were divided into lifelong abstainers and consumers and the latter furtherly divided into quartiles: Q1-Q4. Stratification according to alcohol intake, both current and cumulative as estimated by LACU, showed that very low consumers (C1 and Q1-Q3) displayed lower frequency of cirrhosis and hepatocellular carcinoma compared to abstainers and moderate consumers (C2 and Q4). We can speculate that up to one glass of wine daily in the context of a Mediterranean diet may be a long-term useful approach in selected NAFLD patients.


Subject(s)
Carcinoma, Hepatocellular , Liver Neoplasms , Non-alcoholic Fatty Liver Disease , Alcohol Drinking/adverse effects , Alcohol Drinking/epidemiology , Carcinoma, Hepatocellular/complications , Carcinoma, Hepatocellular/etiology , Female , Fibrosis , Humans , Liver Cirrhosis/complications , Liver Neoplasms/epidemiology , Liver Neoplasms/etiology , Male , Non-alcoholic Fatty Liver Disease/complications , Non-alcoholic Fatty Liver Disease/etiology , Prevalence , Risk Factors
2.
Sensors (Basel) ; 22(3)2022 Feb 04.
Article in English | MEDLINE | ID: mdl-35161936

ABSTRACT

Considering the consistent reduction in battery range due to the operation of the Heating Ventilation and Air Conditioning (HVAC) system, this study deals with the CO2 measurement inside the cabin of an electric crane and aims to reduce the energy consumption through the control of the air recirculation. A control strategy was defined and tested through an experimental set-up where the presence of a driver was simulated as a source of CO2. The cabin was placed inside a climatic wind tunnel and the benefits of this control strategy on the HVAC system energy consumption were assessed, both in the heating and the cooling modes. In addition, we discussed the optimal position of the CO2 sensor inside the cabin by comparing the results obtained from some sensors placed around the cabin occupant with the ones logged by three sensors in the breathing zone. Finally, an investigation of the uncertainty of the indirect measurement of the leakage flow and its dependence on the number of CO2 sensors installed in the cabin was made through the Monte Carlo method.


Subject(s)
Air Conditioning , Air Pollution, Indoor , Air Pollution, Indoor/analysis , Carbon Dioxide/analysis , Heating , Ventilation
3.
Fam Pract ; 39(4): 656-661, 2022 07 19.
Article in English | MEDLINE | ID: mdl-35018438

ABSTRACT

INTRODUCTION: Lung ultrasound (LUS) has become the first diagnostic imaging approach to assess lung involvement in COVID-19. While LUS proved to be safe, reliable, and accurate, not many primary care physicians (PCP) are capable to employ this instrument in the first evaluation of COVID-19 outpatients. The aim of this study was to determine the effectiveness of a brief training program in LUS for PCP. METHODS: Italian local authorities promoted a training program in LUS for PCP engaged in COVID-19 outpatients' evaluation. The course took place in a COVID-19 unit and included a hands-on practice on real COVID-19 patients. We conducted a qualitative and quantitative analysis of the results of the training program. RESULTS: A total of 32 PCP completed the training. About 100% of participants reported an increase in competence and confidence in the use of LUS after the training. Self-reported confidence in detecting major COVID-19 LUS abnormalities was high (B-lines 8/10, pleural abnormalities 6.5/10). B-lines were accurately identified with a reliability of 81%, with a sensitivity of 96%, and a negative predictive value of 98%. Trainees were some less accurate in detecting pleural abnormalities (reliability 63%) but with a high specificity (99%). CONCLUSIONS: This study showed that a short training program, but comprising a hands-on practice, is capable to bring even almost novices to achieve a high overall accuracy and reliability in detecting lung involvement in COVID-19. This may result in a significant improvement of the performances of PCP involved in the first evaluation of COVID-19 cases in primary care facilities.


Subject(s)
COVID-19 , Physicians, Primary Care , COVID-19/diagnostic imaging , Humans , Lung/diagnostic imaging , Reproducibility of Results , SARS-CoV-2 , Ultrasonography/methods
4.
Cancers (Basel) ; 13(4)2021 Feb 03.
Article in English | MEDLINE | ID: mdl-33546234

ABSTRACT

BACKGROUND: Hepatocellular carcinoma (HCC) factors, especially maximum tumor diameter (MTD), tumor multifocality, portal vein thrombosis (PVT), and serum alpha-fetoprotein (AFP), influence survival. AIM: To examine patterns of tumor factors in large HCC patients. METHODS: A database of large HCC patients was examined. RESULTS: A multiple Cox proportional hazard model on death identified low serum albumin levels and the presence of PVT and multifocality, with each having a hazard ratio ≥2.0. All combinations of these three parameters were examined in relation to survival. Using univariate Cox analysis, the combination of albumin >3.5 g/dL and the absence of both PVT and multifocality had the best survival rate, while all combinations that included the presence of PVT had poor survival and hazard ratios. We identified four clinical phenotypes, each with a distinct median survival: patients with or without PVT or multifocality plus serum albumin ≥3.5 (g/dL), with each subgroup displaying high (≥100 IU/mL) or low (<100 IU/mL) blood AFP levels. Across a range of MTDs, we identified only two significant trends, blood AFP and platelets. CONCLUSIONS: Patients with large HCCs have distinct phenotypes and survival, as identified by the combination of PVT, multifocality, and blood albumin levels.

SELECTION OF CITATIONS
SEARCH DETAIL